This beaten-down biotech stock is a cure for your portfolio By: MarketWatch August 09, 2016 at 05:08 AM EDT If you only ever buy shares of one biotech company, Gilead Sciences is the one and now is the time, writes Michael Brush. Read More >> Related Stocks: Gilead Sciences